Tscan Therapeutics Inc
(TCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 6,803 | 3,095 | 3,363 | 4,056 | 3,021 |
| Gross Profit | 6,803 | 3,095 | 3,363 | 4,056 | 3,021 |
| Operating Expenses | 29,546 | 21,744 | 19,941 | 19,302 | 19,184 |
| Operating Income | -22,743 | -18,649 | -16,578 | -15,246 | -16,163 |
| Interest Expense | 956 | 975 | 201 | 0 | 0 |
| Other Income | 1,136 | 901 | 534 | 149 | 7 |
| Pre-tax Income | -22,563 | -18,723 | -16,245 | -15,097 | -16,156 |
| Net Income Continuous | -22,563 | -18,723 | -16,245 | -15,097 | -16,156 |
| Net Income | $-22,563 | $-18,723 | $-16,245 | $-15,097 | $-16,156 |
| EPS Basic Total Ops | -0.93 | -0.78 | -0.67 | -0.63 | -0.67 |
| EPS Basic Continuous Ops | -0.93 | -0.78 | -0.67 | -0.63 | -0.67 |
| EPS Diluted Total Ops | -0.93 | -0.78 | -0.67 | -0.63 | -0.67 |
| EPS Diluted Continuous Ops | -0.93 | -0.78 | -0.67 | -0.63 | -0.67 |
| EBITDA(a) | $-21,244 | $-17,165 | $-15,327 | $-14,039 | $-14,968 |